<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04230291</url>
  </required_header>
  <id_info>
    <org_study_id>1910019510</org_study_id>
    <nct_id>NCT04230291</nct_id>
  </id_info>
  <brief_title>Hidradenitis Suppurativa Written Action Plan</brief_title>
  <acronym>HSWAP</acronym>
  <official_title>Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arizona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arizona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being conducted to evaluate if a written action plan for hidradenitis
      suppurativa (HS) will help patients with hidradenitis suppurativa gain a better understanding
      of the condition and how to manage the condition on a daily basis compared to a routine
      verbal consultation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 24, 2020</start_date>
  <completion_date type="Anticipated">January 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visits to high-cost care settings</measure>
    <time_frame>12 months</time_frame>
    <description>Number of visits to ER, urgent care, or hospitalizations because of HS</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hidradenitis Suppurativa</condition>
  <arm_group>
    <arm_group_label>Verbal Consultation, then Written Action Plan</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>CONTROL GROUP
Survey A
Routine clinic visit
Verbal consultation only
Survey B
Verbal consultation AND Written Action Plan
Survey C</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Written Action Plan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>INTERVENTION GROUP
Survey A
Routine clinic visit
Verbal consultation AND Written Action Plan
Survey C</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Verbal consultation</intervention_name>
    <description>Verbal consultation only without written information before receiving written action plan</description>
    <arm_group_label>Verbal Consultation, then Written Action Plan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Written Action Plan</intervention_name>
    <description>Written handout of treatment plan and disease management strategies</description>
    <arm_group_label>Verbal Consultation, then Written Action Plan</arm_group_label>
    <arm_group_label>Written Action Plan</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Has a diagnosis of HS

        Exclusion Criteria:

          -  Has been exposed to a written action plan for HS before
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Vivian Y Shi</last_name>
    <phone>5206948888</phone>
    <email>vshi@email.arizona.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Banner - University Medicine Dermatology Clinic</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85718</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vivian Y Shi, MD</last_name>
      <phone>520-694-8888</phone>
      <email>vshi@email.arizona.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 13, 2020</study_first_submitted>
  <study_first_submitted_qc>January 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Arizona</investigator_affiliation>
    <investigator_full_name>Vivian Shi</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hidradenitis Suppurativa</mesh_term>
    <mesh_term>Hidradenitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

